Wealth Enhancement Advisory Services’s Ingredion INGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Sell
20,272
-14,913
-42% -$1.58M ﹤0.01% 1941
2026
Q1
$2.9M Buy
35,185
+7,232
+26% +$830K 0.01% 1199
2025
Q4
$3.12M Buy
27,953
+4,895
+21% +$552K ﹤0.01% 1263
2025
Q3
$2.78M Buy
23,058
+9,009
+64% +$1.16M ﹤0.01% 1259
2025
Q2
$1.93M Buy
14,049
+1,744
+14% +$235K ﹤0.01% 1370
2025
Q1
$1.66M Buy
12,305
+1,114
+10% +$147K ﹤0.01% 1340
2024
Q4
$1.54M Buy
11,191
+905
+9% +$127K ﹤0.01% 1312
2024
Q3
$1.41M Sell
10,286
-39
-0.4% -$4.96K ﹤0.01% 1222
2024
Q2
$1.18M Sell
10,325
-127
-1% -$14.7K ﹤0.01% 1199
2024
Q1
$1.22M Buy
10,452
+487
+5% +$54.8K ﹤0.01% 1146
2023
Q4
$1.08M Sell
9,965
-1,498
-13% -$150K ﹤0.01% 1144
2023
Q3
$1.13M Buy
+11,463
New +$1.19M ﹤0.01% 1049

Other funds holding INGR

Wealth Enhancement Advisory Services's INGR Position: Q2 2026 in Review

Wealth Enhancement Advisory Services reduced its Ingredion (INGR) stake by 42% in Q2 2026, selling an estimated $1.58M and leaving 20,272 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1941.

Wealth Enhancement Advisory Services first reported a position in INGR in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.12M in Q4 2025. 612 funds tracked by Wall St. Rank hold INGR as of Q2 2026.

  • Wealth Enhancement Advisory Services held 20,272 shares of Ingredion worth $1.2M as of Q2 2026.
  • Wealth Enhancement Advisory Services sold 14,913 Ingredion shares in Q2 2026, an estimated $1.58M.
  • Ingredion made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #1941 holding.
  • Wealth Enhancement Advisory Services first reported a position in Ingredion in Q3 2023 and has held it in 12 quarters since.
  • Wealth Enhancement Advisory Services's Ingredion position peaked at $3.12M in Q4 2025.
  • 612 funds tracked by Wall St. Rank held Ingredion as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.